drugset / Trial / NCT01766180

Cerebrovascular and Cognitive Improvement by Resveratrol (resVida) and Fruitflow-II (CCIRF-II)

NCT01766180

RandomizedFactorialQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether Fruitflow-II, Resveratrol (resVida), alone or in combination, are effective in the treatment of memory problems in adult patients with memory impairment. We also evaluate effects of these medications on blood flow to the brain and fitness, to find whether the possible improvement in memory is associated with the alterations in these parameters.

Timeline

Start
2013-01
Primary completion
2016-01
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fruitflow-II Unknown 150 mg Oral
Comparator Resveratrol Small molecule 150 mg Oral

Indications